240
Participants
Start Date
May 31, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
May 31, 2008
Fampridine-SR
Tablets, 10 mg, twice daily, 9 weeks
Placebo
placebo (sugar pill)
Corinne Goldsmith Dickinson Center for MS, New York
Columbia University Multiple Sclerosis Clinical Care Center, New York
SUNY Stony Brook, Stony Brook
Jacobs Neurological Institute Buffalo General Hospital, Buffalo
University of Rochester, Rochester
Thomas Jefferson University Physicians, Philadelphia
Maryland Center for MS, Baltimore
CAMC Health Education & Research Institute, Charleston
Wake Forest University, Dept of Neurology, M.S. Research, Winston-Salem
Raleigh Neurology Associates, Raleigh
CMC - Neuroscience & Spine Institute, Division of Neurology, Charlotte
Shepherd Center, Atlanta
Associates in Neurology, PSC, Lexington
Ohio State University MS Center, Columbus
Cleveland Clinic Foundation, Cleveland
Indiana University MS Center, Indianapolis
Center for Neurological Disorders of Aurora, St. Luke's Medical Center, Milwaukee
The Schapiro Center for MS, Golden Valley
The Center for Neurological Services, Bismarck
Advanced Neurology Specialists, Great Falls
Consultants in Neurology, Ltd., Northbrook
Washington University School of Medicine, St Louis
Neurological Associates, Fayetteville
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center, Phoenix
HOPE Research Institute, Phoenix
USC, Keck School of Medicine Health Care Consultation Center, Los Angeles
Alta Bates Summit Medical Center - Research and Education Institute, Berkeley
UC Davis, Sacramento
Oregon Health & Science University, MS Center of Oregon, UHS-42, Portland
MS Center at Evergreen, Kirkland
Yale University MS Center, New Haven
Lahey Clinic, Lexington
UMDNJ, Newark
Gimbel MS Center at Holy Name Hospital, Teaneck
Neurological Research Center, Inc., Bennington
Fletcher Allen Health Care, Burlington
Foothills Medical Center, Calgary
University of British Columbia, Vancouver Coastal Health Research Institute, Vancouver
River Valley Health c/o Stan Cassidy Centre for Rehabilitation, Fredericton
QEII Health Sciences Centre, Nova Scotia Rehabilitation Centre Site, Halifax
Lead Sponsor
Acorda Therapeutics
INDUSTRY